SunOpta (STKL) Reports Earnings Tomorrow: What To Expect Plant-based food and beverage company SunOpta (NASDAQ:STKL) will be reporting results tomorrow after market close. Here’s what to look for. SunOpta beat analysts’ revenue expectations by 0.8% last quarter, reporting revenues of $176.2 million, up 15.5% year on year. It was a mixed quarter for the company, with full-year revenue guidance meeting analysts’ expectations but a significant miss of analysts’ gross margin estimates. Is SunOpta a buy or sell going into earnings? Read our full analysis here, it’s free. This quarter, analysts are expecting SunOpta’s revenue to grow 6.7% year on year to $193.7 million, slowing from the 13.7% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.06 per share.SunOpta Total Revenue Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. SunOpta has missed Wall Street’s revenue estimates four times over the last two years. Looking at SunOpta’s peers in the shelf-stable food segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Hershey delivered year-on-year revenue growth of 8.7%, beating analysts’ expectations by 1.6%, and Lancaster Colony reported revenues up 4.8%, topping estimates by 2.8%. Hershey traded up 6.2% following the results while Lancaster Colony was also up 11.9%. Read our full analysis of Hershey’s results here and Lancaster Colony’s results here. Inflation has progressed towards the Fed’s 2% goal as of late, leading to strong stock market performance. Recent rate cuts and the 2024 Presidential election's conclusion added further sparks to the market, and while some of the shelf-stable food stocks have shown solid performance, the group has generally underperformed, with share prices down 2.5% on average over the last month. SunOpta is down 4.4% during the same time and is heading into earnings with an average analyst price target of $10.17 (compared to the current share price of $7.14). When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback. View Comments
SunOpta (STKL) Reports Earnings Tomorrow: What To Expect
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...